Literature DB >> 16609085

Constraints on publication rights in industry-initiated clinical trials.

Peter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, Mette T Haahr, Douglas G Altman, An-Wen Chan.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2006        PMID： 16609085     DOI： 10.1001/jama.295.14.1645

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  29 in total

Review 1.  The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Klaus Lieb; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

Review 2.  Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Int J Clin Pharm       Date:  2014-02-23

3.  Freedom of Science - Can Industry Influence What Scientists Publish?

Authors:  Ralph Ziegler; Oliver Schnell; Bernd Kulzer; James Gilbart; Lutz Heinemann
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

5.  Searching ClinicalTrials.gov and the International Clinical Trials Registry Platform to inform systematic reviews: what are the optimal search approaches?

Authors:  Julie M Glanville; Steven Duffy; Rachael McCool; Danielle Varley
Journal:  J Med Libr Assoc       Date:  2014-07

Review 6.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

Review 7.  Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.

Authors:  Peter C Gøtzsche; Helle Krogh Johansen
Journal:  Cochrane Database Syst Rev       Date:  2016-09-20

8.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

9.  SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krle A-Jerić; Asbjørn Hrobjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Dore; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Rev Panam Salud Publica       Date:  2015-12

10.  Redactions in protocols for drug trials: what industry sponsors concealed.

Authors:  Mikkel Marquardsen; Michelle Ogden; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2018-01-25       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.